Cover Image
市場調查報告書

Ferring International Center S.A.:產品平台分析

Ferring International Center S.A. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 308915
出版日期 內容資訊 英文 49 Pages
訂單完成後即時交付
價格
Back to Top
Ferring International Center S.A.:產品平台分析 Ferring International Center S.A. - Product Pipeline Review - 2016
出版日期: 2016年02月24日 內容資訊: 英文 49 Pages
簡介

Ferring International Center S.A. 是在生殖健康、泌尿系統疾病、腸胃病、內分泌疾病、骨關節炎等領域開發、製造、供給生物醫藥品的生物醫藥品企業,其事業廣及全球50個以上的國家。

本報告提供Ferring International Center S.A.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Ferring International Center S.A.的基本資料

Ferring International Center S.A.概要

  • 主要資訊
  • 企業資料

Ferring International Center S.A.:R&D概要

  • 主要的治療範圍

Ferring International Center S.A.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Ferring International Center S.A.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Ferring International Center S.A.:藥物簡介

  • degarelix
  • follitropin delta
  • Testavan
  • barusiban
  • FE-202767
  • FE-992097
  • FE-999309
  • selepressin
  • FE-204205
  • FE-999301
  • FE-201874
  • FE-203799
  • FE-999310

Ferring International Center S.A.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Ferring International Center S.A.:最近的開發平台趨勢

Ferring International Center S.A.:暫停中的計劃

Ferring International Center S.A.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07957CDB

Summary

Global Markets Direct's, 'Ferring International Center S.A. - Product Pipeline Review - 2016', provides an overview of the Ferring International Center S.A.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ferring International Center S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Ferring International Center S.A.
  • The report provides overview of Ferring International Center S.A. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Ferring International Center S.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Ferring International Center S.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Ferring International Center S.A.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Ferring International Center S.A.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Ferring International Center S.A.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ferring International Center S.A. Snapshot
    • Ferring International Center S.A. Overview
    • Key Information
    • Key Facts
  • Ferring International Center S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Ferring International Center S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Ferring International Center S.A. - Pipeline Products Glance
    • Ferring International Center S.A. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Ferring International Center S.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Ferring International Center S.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Ferring International Center S.A. - Drug Profiles
    • follitropin delta
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Testavan
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • degarelix acetate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • elobixibat
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • selepressin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • barusiban
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • carbetocin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FE-999301
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • merotocin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FE-201874
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FE-204038
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FE-999310
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ferring International Center S.A. - Pipeline Analysis
    • Ferring International Center S.A. - Pipeline Products by Target
    • Ferring International Center S.A. - Pipeline Products by Route of Administration
    • Ferring International Center S.A. - Pipeline Products by Molecule Type
    • Ferring International Center S.A. - Pipeline Products by Mechanism of Action
  • Ferring International Center S.A. - Recent Pipeline Updates
  • Ferring International Center S.A. - Dormant Projects
  • Ferring International Center S.A. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • DR-2011
  • Ferring International Center S.A. - Locations and Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ferring International Center S.A., Key Information
  • Ferring International Center S.A., Key Facts
  • Ferring International Center S.A. - Pipeline by Indication, 2016
  • Ferring International Center S.A. - Pipeline by Stage of Development, 2016
  • Ferring International Center S.A. - Monotherapy Products in Pipeline, 2016
  • Ferring International Center S.A. - Partnered Products in Pipeline, 2016
  • Ferring International Center S.A. - Partnered Products/ Combination Treatment Modalities, 2016
  • Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2016
  • Ferring International Center S.A. - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • Ferring International Center S.A. - Pre-Registration, 2016
  • Ferring International Center S.A. - Phase III, 2016
  • Ferring International Center S.A. - Phase II, 2016
  • Ferring International Center S.A. - Preclinical, 2016
  • Ferring International Center S.A. - Pipeline by Target, 2016
  • Ferring International Center S.A. - Pipeline by Route of Administration, 2016
  • Ferring International Center S.A. - Pipeline by Molecule Type, 2016
  • Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2016
  • Ferring International Center S.A. - Recent Pipeline Updates, 2016
  • Ferring International Center S.A. - Dormant Developmental Projects,2016
  • Ferring International Center S.A. - Discontinued Pipeline Products, 2016
  • Ferring International Center S.A., Other Locations
  • Ferring International Center S.A., Subsidiaries

List of Figures

  • Ferring International Center S.A. - Pipeline by Top 10 Indication, 2016
  • Ferring International Center S.A. - Pipeline by Stage of Development, 2016
  • Ferring International Center S.A. - Monotherapy Products in Pipeline, 2016
  • Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2016
  • Ferring International Center S.A. - Pipeline by Target, 2016
  • Ferring International Center S.A. - Pipeline by Route of Administration, 2016
  • Ferring International Center S.A. - Pipeline by Molecule Type, 2016
  • Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2016
Back to Top